Ashwagandha: The Benefits and Risks, With the Trial Numbers
In this article
- What is ashwagandha?
- What does ashwagandha do to the body?
- Does ashwagandha lower cortisol and stress?
- Does ashwagandha help you sleep?
- What does ashwagandha do for men?
- What does ashwagandha do for women?
- How long does ashwagandha take to work?
- How do you read an ashwagandha label?
- Is ashwagandha safe?
- What we don't know
- Frequently asked questions
Ashwagandha is the root of Withania somnifera, a shrub in the nightshade family used in Ayurvedic practice for centuries and sold in the UK as a food supplement with no authorised health claim. Its trials are small and short, and the results are modest: in a 2012 trial of 64 stressed adults, 600 mg of root extract a day for 60 days lowered serum cortisol by about 28% against 8% on placebo; in 60 people with insomnia, the same dose for 10 weeks left the time to fall asleep about 5 minutes shorter than on placebo; and in men, 23 pooled trials put testosterone about 57 ng/dL higher, inside the normal range, with no significant change in women.1, 2, 3, 7 Two well-run stress trials found no difference from placebo, and about 25 published cases of liver injury sit beside 23 safety trials in 2,317 people whose liver tests stayed normal.4, 5, 6, 7 Regulatory position at 1 November 2026: legal in UK supplements, with open safety questions that the UK Committee on Toxicity is assessing; its draft statement is not yet published.21
Sources checked on 2 November 2026.
- What it is: a root extract standardised to withanolides; the root is what the trials used
- What the trials found: lower stress and anxiety scores with low certainty; about 5 minutes faster to sleep than on placebo in insomnia; testosterone about 57 ng/dL higher in men; more strength in people who train
- Who should not take it: anyone pregnant, breastfeeding or under 18; anyone with liver disease or a thyroid condition, or on sedatives, immunosuppressants or thyroid medicine, without asking first
What is ashwagandha?
Ashwagandha is a small evergreen shrub, Withania somnifera, in the tomato family. Its small orange-red berries sit inside a papery husk, which is where its English name, winter cherry, comes from; the berry is not used. "Indian ginseng" is a nickname for its traditional role as a tonic, not a botanical relationship: it is unrelated to Panax ginseng, and it is a plant, not a mushroom (ashwagandha vs lion's mane compares the two). The root is the part Ayurvedic practice used and the part every trial in this guide tested; products made partly from leaf or stem differ chemically from root-only ones, and a 2026 analysis found that the commercial use of these aerial parts raises quality and safety concerns, which is why the plant part on a label matters.8 The active constituents are the withanolides, steroidal lactones to which extracts are standardised.
What does ashwagandha do to the body?
In laboratory work, compounds isolated from the root enhanced GABA-A receptor activity, the most active being a ferulic acid ester rather than a withanolide; how that translates to people is not established.25 In people, the most complete picture is a 2026 pooling of 23 randomised trials in 1,706 adults: cortisol lower (standardised mean difference -1.18), serotonin higher, thyroxine up 0.61 µg/dL with TSH and T3 unchanged, and testosterone up in men only.3 In the 23 safety trials, mild stomach upset, headache and drowsiness were infrequent and about as common on placebo.7 It is a food supplement, not a medicine: the trials in insomnia, subclinical hypothyroidism, low sperm count and anxiety disorders are evidence, not licensed uses.
Does ashwagandha lower cortisol and stress?
The number everyone quotes comes from one trial. In 2012, 64 adults with chronic stress took 300 mg of root extract twice daily or placebo for 60 days: every stress scale fell more on ashwagandha, and serum cortisol fell 27.9% against 7.9% on placebo.1 That single trial, on an extract its manufacturer supplied, is where "lowers cortisol by 30%" comes from. In 60 stressed adults in India, 240 mg a day for 60 days lowered Hamilton anxiety scores and morning cortisol against placebo.9 Pooled across 12 trials and 1,002 people, anxiety fell by a standardised mean difference of 1.55 and stress by 1.75, with the trials disagreeing widely (heterogeneity 84 to 94%) and low certainty.10 Nine trials pooled in 2024 give scale points: perceived stress 4.7 points lower on a 0 to 40 scale and Hamilton anxiety 2.2 points lower on a 0 to 56 scale.11 A 2025 pooling of seven cortisol trials and six perceived-stress trials (488 people) found cortisol about 1.2 µg/dL lower than on placebo but no significant difference in perceived stress, so the poolings agree on cortisol and disagree on stress scores.32 Two careful trials were null: 60 adults on 225 or 400 mg a day of a root-and-leaf extract improved no more than placebo at 30 days, and 400 mg a day for 12 weeks in overweight adults aged 40 to 75 made no difference to perceived stress, though fatigue was lower.5, 4 None of the nine cortisol studies in a 2023 review looked at what lower cortisol means for adrenal function or over the long term.12
Should you test your cortisol first? No trial selected people by cortisol, a single reading swings by the hour, and GPs test cortisol to look for disease, not to plan a supplement (what is cortisol). Nothing has been compared with ashwagandha head to head, so "what is more powerful" has no trial answer; for a diagnosed anxiety disorder the GP and NHS talking therapies come first. The brain, including the flatness some users describe, is on what ashwagandha does for the brain.
Does ashwagandha help you sleep?
By minutes. In 60 people with insomnia, 300 mg twice daily for 10 weeks shortened the time to fall asleep, measured by a wrist monitor, to 29.0 minutes against 33.9 on placebo, and raised sleep efficiency to 83.5% against 79.7%: about 5 minutes and 4 points.2 Pooled over five trials of 400 people, four from one research group, the effect was small but significant (standardised mean difference -0.59) and larger in diagnosed insomnia, at 600 mg a day and after 8 weeks or more.13 Where a sleep blend pairs ashwagandha with magnesium, any authorised wording on it belongs to the magnesium: it contributes to normal psychological function and to a reduction of tiredness and fatigue.30 Magnesium's own sleep trials are on does magnesium help you sleep, in the Wellgard sleep guide, and sour cherry's three small trials on do sour cherries help you sleep, what tart cherry is good for and tart cherry juice warnings. Melatonin is a prescription-only medicine in the UK, and no supplement is a source of it.
What does ashwagandha do for men?
Three measurable things. Testosterone: across the 23 pooled trials it rose by about 57 ng/dL in men, within the normal range, with oestradiol unchanged.3, 7 In 57 overweight men aged 40 to 70, salivary testosterone rose 14.7% more than on placebo over 8 weeks, with no difference in fatigue, vigour or sexual well-being.14 Strength: across 20 trials the effect was moderate (standardised mean difference 0.58), large in people who train (1.03) and absent in the untrained.15 In 57 young men new to resistance training, 300 mg twice daily for 8 weeks added 46.0 kg to the bench press against 26.4 kg on placebo.16 Fertility: in 46 men with low sperm counts, 675 mg a day for 90 days raised sperm count from 9.6 to 25.6 million per mL, a 167% rise, with little change on placebo; it is the only randomised trial in the 2018 fertility review.17, 18 So the testosterone answer is a number, not a boost; the US National Institutes of Health's complementary-health institute advises men with hormone-sensitive prostate cancer to avoid it for that reason.
What does ashwagandha do for women?
The stress, anxiety and sleep trials enrolled women and men together, so the numbers above are the best guide for women. The hormonal picture differs: testosterone did not rise significantly in women in the pooled trials, and oestradiol did not change.3 Three small placebo-controlled trials in India, of 100, 60 and 66 women, reported lower menopause-symptom scores than placebo over 8 to 12 weeks, and no product may claim a menopause effect.24 Two cautions weigh more on women. The French food-safety agency advises against ashwagandha in pregnancy and, as a precaution, while breastfeeding, and the NHS says not to take herbal medicines when pregnant or breastfeeding.26, 27 And because an overactive thyroid is about 10 times more common in women than in men, the one direction the trials show for thyroxine, up, matters: anyone with a thyroid condition or on levothyroxine asks their GP first.29, 3
How long does ashwagandha take to work?
Weeks, not days. Most trials reported their results at about 8 weeks, a few ran to 180 days, and the one 30-day trial found no difference from placebo.15, 7, 5 The insomnia trial measured at 10 weeks, the stress trials at 60 days, the strength trial at 8 weeks.1, 2, 16 A fair personal trial is 8 weeks at a label dose, noting sleep, mood or training before and after. How long to continue, whether to cycle it and what happens when you stop are on is ashwagandha safe to take daily.
How do you read an ashwagandha label?
Three things decide what a product delivers. First, the plant part. A 2026 analysis tested 25 ashwagandha products on sale against the British and US Pharmacopoeia standards: more than 44% failed the British withanolide standard, 60% failed the American one, and only two were confirmed as made from root, the rest containing varying proportions of leaf or stem, disclosed on the label or not.8 Second, extract against whole root. A capsule stating "300 mg of a 10:1 root extract" and one stating "equivalent to 3,000 mg of whole root" describe the same dose; the trials used 240 to 600 mg a day of standardised root extract, so compare the extract figure with that. Third, standardisation: a stated withanolide percentage or milligrams of withanolide glycosides, as the trials' extracts had.
Formats differ in what a serving delivers. A capsule usually carries a standardised root extract in the hundreds of milligrams, with a root-only statement on the pack where that applies; a gummy usually carries a smaller extract dose, often with vitamin B6, and where B6 is present at 15% or more of the reference intake the wording on that pack belongs to the B6: vitamin B6 contributes to normal psychological function and to the reduction of tiredness and fatigue.30 Gummies, capsules and powders are not ranked here; the label says what each delivers. Ashwagandha itself has no authorised health claim in Great Britain, so no product carries one.
Is ashwagandha safe?
The liver first. To December 2025, 25 patients in 13 published reports developed liver injury linked to ashwagandha, typically after weeks of use and usually cholestatic or mixed, with jaundice and itching; most recovered over weeks to months after stopping; one person needed a transplant; and three died, all with existing cirrhosis.6 In the first case series, of five patients, injury began 2 to 12 weeks after starting, liver tests returned to normal within 1 to 5 months in the four followed up, and analysis of the supplements found no other toxic compound.19 Beside that sit 23 trials of standardised root-only extract in 2,317 healthy adults for up to 180 days, with liver, kidney, blood, hormone and heart markers inside normal ranges; the review notes that trials this short may not capture rare or idiosyncratic reactions.7 Dark urine, pale stools, itching, yellow skin or eyes, nausea or pain under the right ribs mean stop and get medical advice the same day; for yellow skin or eyes the NHS says to ask for an urgent GP appointment or get help from NHS 111.28, 19 A suspected reaction to a food supplement can be reported to your local authority's food safety team, which works with the Food Standards Agency.23 Thyroxine rises and TSH does not, so thyroid conditions and thyroid medicines need the GP's agreement first.3 Pregnancy, breastfeeding and under-18s: no. Sedatives, immunosuppressants, diabetes and blood-pressure medicines: tell your pharmacist first.26, 27 Denmark alone prohibits it in food, after a 2020 risk assessment that could set no intake free of risk; the French and German food-safety bodies advised in 2024 that pregnant and breastfeeding women, children and people with liver disease should not take it, without a ban.26 In the UK it is legal in supplements, with open safety questions that the UK Committee on Toxicity is assessing; its draft statement is not yet published.20, 21 The full dated record, the medicine table and the kidney, heart and thyroid questions are on who should not take ashwagandha.
What we don't know
Whether any benefit lasts, or daily use stays safe, beyond 180 days: no placebo-controlled trial has run longer.7 Whether a lower cortisol reading changes health: none of the cortisol studies looked at adrenal function or long-term effects.12 How often liver injury happens and why only some people develop it: 25 published cases cannot give a rate.6 And whether results carry from one product to another: most safety trials used a single root extract, and two stress trials of other extracts found no difference from placebo.7, 4, 5
Frequently asked questions
Is ashwagandha also called Indian ginseng, and what is its English name?
Yes, as a nickname for its traditional use as a tonic; it is not related to ginseng. Its English name is winter cherry, after the husked berries, and its botanical name is Withania somnifera, the species name meaning "sleep-inducing".
Is ashwagandha a steroid?
No. Ashwagandha is a plant root extract, not an anabolic steroid or a corticosteroid medicine, and it contains no hormone. Its active compounds, the withanolides, are called steroidal lactones because their carbon skeleton has the four-ring shape chemists call a steroid. In 23 pooled trials of 1,706 adults, testosterone rose by about 57 ng/dL in men, within the normal range, and did not change significantly in women.3, 7
Does ashwagandha help with weight loss or "cortisol belly"?
One trial of 52 adults under chronic stress recorded body weight as a secondary outcome over 8 weeks on 300 mg twice daily and reported it lower than on placebo without giving the size in its abstract.22 One trial has since made weight its main outcome: 100 adults in Mumbai with a body mass index of 25 to 39.9 took 300 mg of root extract twice daily or placebo for 24 weeks (91 analysed), and weight and body mass index fell more on ashwagandha than on placebo; it is a single-centre trial on an extract its maker supplied, not yet repeated, and pooled across 20 trials ashwagandha did not change body weight or body fat.31, 15 Ashwagandha has no authorised health claim in Great Britain, for weight or any other effect.30
What does ashwagandha do to your face?
No trial has measured skin or facial appearance; the one thing to watch on the face is the liver warning: yellowing of the skin or eyes after starting ashwagandha is a reason to stop and see a GP that day.
What vitamins or drinks help with stress?
Two nutrients carry authorised wording: vitamin B6 and magnesium each contribute to normal psychological function and to normal functioning of the nervous system, vitamin B6 to the reduction of tiredness and fatigue and magnesium to a reduction of tiredness and fatigue.30
Sources
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 2012. Randomised placebo-controlled trial, 64 adults with chronic stress, 60 days; extract supplied by its maker, no other support declared. PubMed 23439798.
- Langade D, et al. Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 2019. Randomised placebo-controlled trial, 60 adults with insomnia, 10 weeks; extract supplied by its maker, no competing interests declared. PubMed 31728244.
- Fornalik M, et al. Hormonal modulation with Withania somnifera: systematic review and meta-analysis of randomized-controlled trials. Planta Medica, 2026. Systematic review and meta-analysis, 23 randomised trials, 1,706 adults; no conflicts declared, funder not stated. PubMed 41740946.
- Smith SJ, et al. Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial. Journal of Psychopharmacology, 2023. Randomised placebo-controlled trial, 120 adults aged 40 to 75, 12 weeks; funded by the extract's maker. PubMed 37740662.
- Remenapp A, et al. Efficacy of Withania somnifera supplementation on adult's cognition and mood. Journal of Ayurveda and Integrative Medicine, 2022. Randomised placebo-controlled trial, 60 adults, 30 days; funded by the extract's maker. PubMed 34838432.
- McIntyre D, et al. Ashwagandha (Withania somnifera)-associated liver injury: a scoping review of clinical characteristics and safety considerations. Cureus, 2026. Scoping review, 13 case publications, 25 patients; no funding received. PubMed 42367407.
- Coope OC, et al. Back to the roots: safety and tolerability of standardised ashwagandha (Withania somnifera) root extract in healthy adults, a systematic review of biomarkers and adverse events. Pharmaceuticals, 2026. Systematic review, 23 randomised trials, 2,317 healthy adults; no external funding, two authors employed by UK supplement companies. PubMed 42198398.
- Avula B, et al. A comparison of British and US Pharmacopoeia standards for quality of ashwagandha dietary supplements in commerce. Phytotherapy Research, 2026. Laboratory analysis of 25 supplement products; US Department of Agriculture and Food and Drug Administration funding. PubMed 41386716.
- Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine, 2019. Randomised placebo-controlled trial, 60 stressed adults, 60 days; funded by the extract's maker. PubMed 31517876.
- Akhgarjand C, et al. Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 2022. Systematic review and meta-analysis, 12 randomised trials, 1,002 adults, low certainty; funder not stated in the abstract. PubMed 36017529.
- Arumugam V, et al. Effects of ashwagandha (Withania somnifera) on stress and anxiety: a systematic review and meta-analysis. Explore, 2024. Systematic review and meta-analysis, 9 randomised trials, 558 people; funder not stated in the abstract. PubMed 39348746.
- Della Porta M, et al. Effects of Withania somnifera on cortisol levels in stressed human subjects: a systematic review. Nutrients, 2023. Systematic review, 9 studies; no external funding. PubMed 38140274.
- Cheah KL, et al. Effect of ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One, 2021. Systematic review and meta-analysis, 5 randomised trials, 400 adults; no competing interests declared. PubMed 34559859.
- Lopresti AL, et al. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. American Journal of Men's Health, 2019. Randomised placebo-controlled crossover trial, 57 men aged 40 to 70, 8 weeks per phase; funded by the extract's maker. PubMed 30854916.
- Zhu X, et al. Effects of Withania somnifera (L.) Dunal (ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. Frontiers in Pharmacology, 2026. Systematic review and meta-analysis, 20 randomised trials, 1,249 adults; public research funding (Shenzhen). PubMed 42199854.
- Wankhede S, et al. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 2015. Randomised placebo-controlled trial, 57 young men, 8 weeks; extract supplied by its maker, no conflicts declared. PubMed 26609282.
- Ambiye VR, et al. Clinical evaluation of the spermatogenic activity of the root extract of ashwagandha (Withania somnifera) in oligospermic males: a pilot study. Evidence-Based Complementary and Alternative Medicine, 2013. Randomised placebo-controlled pilot trial, 46 men with low sperm counts, 90 days; funder not stated, no conflicts declared. PubMed 24371462.
- Durg S, et al. Withania somnifera (Indian ginseng) in male infertility: an evidence-based systematic review and meta-analysis. Phytomedicine, 2018. Systematic review, 4 clinical studies including 1 randomised trial; funder not stated in the abstract. PubMed 30466985.
- Björnsson HK, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 2020. Case series, 5 patients; US National Institutes of Health funding. PubMed 31991029.
- Food Standards Agency. Summary of responses to call for evidence on ashwagandha. Published 25 June 2026; call for evidence 8 July to 2 September 2024, 19 responses. gov.uk.
- Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. 8th September 2026 meeting: third draft statement on ashwagandha discussed; paper TOX/2026/30 not yet available on 1 November 2026. gov.uk.
- Choudhary D, Bhattacharyya S, Joshi K. Body weight management in adults under chronic stress through treatment with ashwagandha root extract: a double-blind, randomized, placebo-controlled trial. Journal of Evidence-Based Complementary and Alternative Medicine, 2017. Randomised placebo-controlled trial, 52 adults under chronic stress, 8 weeks; no conflicts declared, funder not stated. PubMed 27055824.
- Food Standards Agency. How to report a food safety or hygiene issue for members of the public. Updated 5 August 2026. gov.uk.
- Gopal S, et al. J Obstet Gynaecol Res, 2021. Randomised placebo-controlled trial, 100 perimenopausal women, 8 weeks; funder not stated in the abstract. PubMed 34553463; Vani I, et al. Front Reprod Health, 2025. Randomised placebo-controlled trial, 60 women aged 45 to 55, 56 days; extract obtained from its maker, no funding received. PubMed 41561822; Obhrai S, et al. Menopause, 2026. Randomised placebo-controlled trial, 66 postmenopausal women, 12 weeks; no conflicts reported, funder not stated. PubMed 42742071.
- Sonar VP, et al. Ferulic acid esters and withanolides: in search of Withania somnifera GABA-A receptor modulators. Journal of Natural Products, 2019. Laboratory study of compounds isolated from the root; funder not stated in the abstract. PubMed 30998355.
- ANSES (French food-safety agency). Opinion 2021-SA-0077 on the risks of Withania somnifera preparations in food supplements, 19 April 2024, including the Danish (2020) and Dutch (2024) assessments. Expert committee opinion. anses.fr.
- NHS. Herbal medicines and complementary therapies. Page last reviewed 1 May 2026. nhs.uk.
- NHS. Jaundice. Page last reviewed 22 January 2024. nhs.uk.
- NHS. Overactive thyroid (hyperthyroidism). Page last reviewed 11 April 2023 (review overdue). nhs.uk.
- DHSC. Great Britain nutrition and health claims register. gov.uk.
- Pakhale K, et al. Efficacy and safety of Ashwagandha (Withania somnifera) root extract on stress and weight management in adults: a prospective, randomized, double-blind, placebo-controlled study. Journal of Medicine and Life, 2025. Randomised placebo-controlled trial, 100 adults with a body mass index of 25 to 39.9, 24 weeks; extract supplied by its maker, no conflicts declared. PubMed 41635453.
- Albalawi AA. Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress - A systematic review and meta-analysis. Nutrition and Health, 2025. Systematic review and meta-analysis, 7 cortisol and 6 perceived-stress trials, 488 people; no conflicts declared, funder not stated in the abstract. PubMed 40746175.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.